| Mr Solomon Leo Lerer, MD, FACG, | |
|
21110 Biscayne Blvd, # 303, Aventura, FL 33180-1227 | |
| (305) 931-6220 | |
| (305) 466-4755 |
| Full Name | Mr Solomon Leo Lerer |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 53 Years |
| Location | 21110 Biscayne Blvd, Aventura, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013993567 | NPI | - | NPPES |
| 064729200 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | ME0030334 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aventura Hospital And Medical Center | Aventura, FL | Hospital |
| Entity Name | Solomon Lerer Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720382518 PECOS PAC ID: 3173791274 Enrollment ID: O20110715000184 |
News Archive
CEVEC Pharmaceuticals, the German developer of a novel, market leading human protein expression system derived from amniocytes, and Catalent Pharma Solutions, a leading global drug development and delivery solutions provider, announced today a joint commercial cell line development service for pharma and biotech customers worldwide. The offering combines the benefits of CEVEC's human cell line, CAP-Technology, with Catalent's unique GPEx® (Gene Product Expression) Technology to generate high expressing stable human cell lines in a much shorter timeframe than traditional methods.
Nanotechnology offers powerful new possibilities for targeted cancer therapies, but the design challenges are many. Northwestern University scientists now are the first to develop a simple but specialized nanoparticle that can deliver a drug directly to a cancer cell's nucleus - an important feature for effective treatment.
Treatment with mitoxantrone for multiple sclerosis carries only a mildly increased risk of malignancy overall, but the risk of colorectal cancer and leukaemia is heightened, researchers have found.
The Trump administration and drugmakers are squaring off over a proposal to show drug prices in television ads.
The vaccine for human papillomavirus can prevent 90 percent of genital warts in men when offered before exposure to the four HPV strains covered by the vaccine, according to a new multi-center study led by H. Lee Moffitt Cancer Center and UCSF.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Solomon Leo Lerer, MD, FACG, 21110 Biscayne Blvd, # 303, Aventura, FL 33180-1227 Ph: (305) 931-6220 | Mr Solomon Leo Lerer, MD, FACG, 21110 Biscayne Blvd, # 303, Aventura, FL 33180-1227 Ph: (305) 931-6220 |
News Archive
CEVEC Pharmaceuticals, the German developer of a novel, market leading human protein expression system derived from amniocytes, and Catalent Pharma Solutions, a leading global drug development and delivery solutions provider, announced today a joint commercial cell line development service for pharma and biotech customers worldwide. The offering combines the benefits of CEVEC's human cell line, CAP-Technology, with Catalent's unique GPEx® (Gene Product Expression) Technology to generate high expressing stable human cell lines in a much shorter timeframe than traditional methods.
Nanotechnology offers powerful new possibilities for targeted cancer therapies, but the design challenges are many. Northwestern University scientists now are the first to develop a simple but specialized nanoparticle that can deliver a drug directly to a cancer cell's nucleus - an important feature for effective treatment.
Treatment with mitoxantrone for multiple sclerosis carries only a mildly increased risk of malignancy overall, but the risk of colorectal cancer and leukaemia is heightened, researchers have found.
The Trump administration and drugmakers are squaring off over a proposal to show drug prices in television ads.
The vaccine for human papillomavirus can prevent 90 percent of genital warts in men when offered before exposure to the four HPV strains covered by the vaccine, according to a new multi-center study led by H. Lee Moffitt Cancer Center and UCSF.
› Verified 4 days ago
Dr. David Yitzchok Manela, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 2820 Ne 214th St Ste 902, Aventura, FL 33180 Phone: 213-509-5115 | |
Dr. Steven Kobrin, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 2801 Ne 213th St Ste 101, Aventura, FL 33180 Phone: 305-466-7333 Fax: 786-651-2177 | |
Luis Jorge Echarte, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 21110 Biscayne Blvd, Suite 303, Aventura, FL 33180 Phone: 305-466-0030 Fax: 305-466-4755 | |
Nelson Perez Mateu, M.D Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 20601 E Dixie Hwy Ste 340, Aventura, FL 33180 Phone: 786-923-4000 | |
Leonard J Pianko, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 21097 Ne 27th Ct Ste 110, Aventura, FL 33180 Phone: 305-384-4720 Fax: 305-933-1749 | |
Jay E Reinberg, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2845 Aventura Blvd, Suite 247, Aventura, FL 33180 Phone: 305-932-9880 Fax: 305-932-1035 |